Medical Services (CE) (USOTC:MSITF)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Medical Services (CE) Charts. Click Here for more Medical Services (CE) Charts.](/p.php?pid=staticchart&s=NO%5EMSITF&p=8&t=15)
EDMONTON, Alberta, Jan. 8 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that it is on schedule to bring all of its filings up to date, complete the new web site and have an internet site available for the online purchase of its products, particularly the new OTC (Over the Counter) products by mid to late march 2008. The preliminary marketing studies of the new OTC products show that they will do very well and that the demand will be substantial. The Company's existing distributors are very excited to have these new products combined with the existing test kits. The Company has also been able to modify the production of its test kits so that they are available at prices 30% less than previously sold for without affecting the company's profit margins or the accuracy of the test kits. It is felt that this will further increase the demand for the VScan test kits.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies
DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, for Medical Services
International Inc.
Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/